Eicosapentaenoic acid modifies cytokine activity and inhibits cell proliferation in an oesophageal cancer cell line

Anticancer Research

Volumn 33, Issue 10, 2013, Pages 4319-4324

  Kubota, Hisako ^a   Matsumoto, Hideo ^a   Higashida, Masaharu ^a   Murakami, Haruaki ^a   Nakashima, Hiroshi ^a   Oka, Yasuo ^a   Okumura, Hideo ^a   Yamamura, Masahiro ^a   Nakamura, Masahumi ^a   Hirai, Toshihiro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Cytokines; Eicosapentaenoic acid; Esophageal cancer; NF b; TE 1 cells

Indexed keywords

HOE 33342; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROPIDIUM IODIDE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; WST-1 ASSAY;

APOPTOSIS; CYTOKINES; EICOSAPENTAENOIC ACID; ESOPHAGEAL CANCER; NF-ΚB; TE-1 CELLS;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SHAPE; EICOSAPENTAENOIC ACID; ESOPHAGEAL NEOPLASMS; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; NF-KAPPA B; PROTEIN TRANSPORT;

EID: 84891364595     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hattori T, Hamai Y, Ikeda H, Harada T and Ikeda T: Enhancing effect of thoracotomy on tumor growth in rats. Gann 69 : 401-406, 1978.
2. Hirai T, Matsumoto H, Yamashita Y, Urakami A, Iki K, Yamamura M and Tsunoda T: Surgical oncotaxis - Excessive surgical stress and postoperative complications contribute to enhancing tumor metastasis, resulting in a poor prognosis for cancer patients. Ann Thorac Cardiovasc Surg 11: 4-6, 2005.
3. Zubair A and Frieri M: Role of nuclear factor-κB in breast and colorectal cancer. Curr Allergy Asthma Rep 13: 44-49, 2013.
4. Heike LP: Activators and target genes of REL/NF-κB transcription factor. Oncogene 18: 6853-6866, 1999.
5. Aggarwal BB and Sung B: NF-κB in cancer: A matter of life and death. Cancer Discov 1: 469-471, 2011.
6. Kunnumakkara AB, Diagaradjane P, Anand P, Harikumar KB, Deorukhkar A, Gelovani J, Guha S, Krishnan S and Aggarwal BB: Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. Int J Cancer 125: 2187-2197, 2009.
7. Ghosh-Choudhury T, Mandal CC, Woodruff K, St Clair P, Fernandes G, Choudhury GG and Ghosh-Choudhury N: Fish oil targets PTEN to regulate NFκB for down-regulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat. 118 : 213-228, 2009.
8. Zhao Y, Joshi-Barve S, Barve S and Chen LH: Eicosapentanoic acid prevents LPS-induced TNF-α expression by preventing NF-κB activation. J Am Coll Nutr 23: 71-78, 2004.
9. Foglieni C, Meoni C and Davalli AM: Fluorescent dyes for cell viability: An application on prefixed conditions. Histochem Cell Biol 115 : 223-229, 2001.
10. Mikami Y: NF-κB status under operative stress in rats. Kawasaki Med J 35: 147-157, 2009.
11. Spirina LV, Kondakova IV, Choynzonov EL, Chigevskaya SY, Shishkin DA and Kulbakin DY: Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-κB expression in squamous cell carcinoma of head and neck: Association with proteasome and calpain activities. J Cancer Res Clin Oncol 139 : 625-633, 2012.
12. Goldfarb Y, Shapiro H, Singer P, Kalderon Y, Levi B, Glasner A, Benisha M and Ben-Eliyahua S: Fish oil attenuates surgery-induced immunosuppression, limits postoperative metastatic dissemination and increases long-term recurrence-free survival in rodents inoculated with cancer cells. Clin Nutr 31: 396-404, 2012.
13. Calder PC: n-3 Fatty acids, inflammation, and immunity-relevance to postsurgical and critically ill patients. Lipids 39: 1147-1161, 2004.
14. Murphy RA, Yeung E, Mazurak VC and Mourtzakis M: Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer 105: 1469-1473, 2011.
15. Murohy RA, Moutzakis M, Chu QS, Baracos VE, Reiman T and Mazurak VC: Nutritional intervention with fish oil provided a benefit over standard of care for weight and skeletal muscle mass in patients with non-small cell lung cancer receiving chemotherapy. Cancer 117 : 1775-1782, 2011.
16. Wang J, Yu JC, Kang WM and Ma ZQ: Superiority of a fish oil-enriched emulsion to medium-chain triacylglycerols/long-chain triacylglycerols in gastrointestinal surgery patients: A randomized clinical trial. Nutrition 28: 623-629, 2012.
17. Ryan AM, Reynolds JV, Healy L, Byrne M, Moore J, Brannelly N, McHugh A, McCormack D, and Flood P: Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: Results of a double-blinded randomized controlled trial. Ann Surg 249: 355-363, 2009.
18. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC and Tisdale MJ: Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomised double blind trial. Gut 52: 1391-1392, 2003.
19. Hardman WE: (n-3) Fatty acids and cancer therapy. J Nutr 134: 3427S-3430S, 2004.
20. Calder PC: n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S-1519S, 2006.
21. Hagi A, Nakayama M, Shinzaki W, Haji S and Ohyanagi H: Effects of the ω-6:ω-3 fatty acid ratio of fat emulsions on the fatty acid composition in cell membranes and the anti-inflammatory action. J Parenter Enteral Nutr 34: 263-270, 2010.
22. Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR and McMurray DN: Immunomodulatory effects of (n-3) fatty acids: Putative link to inflammation and colon cancer. J Nutr 137: 200S-204S, 2007.